High-Throughput Nanoformulation Screening to Accelerate R&D & De-Risk Development

• Rapidly evaluate diverse nano formulations to identify optimal candidates early
• Streamline delivery design with data-driven screening approaches
• Minimize late-stage failures by de-risking formulation decisions in preclinical R&D

Speakers:

Thomas Moore

Assistant Professor

University of Napoli Federico